Eli Lilly & Co. - Zyprexa
Eli Lilly & Co. - Zyprexa
Company allegedly marketed Zyprexa for treatments that were not approved by FDA, and failed to disclose risk of diabetes from taking the drug in violation of the Tennessee Consumer Protection Act. This was a multistate case.
Press Release
- Tennessee, 32 States, Reach Landmark $62 Million Settlement With Eli Lilly Resolving Improper Marketing Claims (#08-39, October 7, 2008)
State Court Filings in Eli Lilly & Co. - Zyprexa
- Complaint for Injunctive and other Relief (October 7, 2008)
- Agreed Final Judgment (October 7, 2008)
This list includes only significant filings and is not intended to be a complete record of the matter.
